Lazard Asset Management
IONS icon

Lazard Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.4M Sell
60,749
-9
-0% -$356 ﹤0.01% 953
2025
Q1
$1.83M Buy
60,758
+54,201
+827% +$1.63M ﹤0.01% 998
2024
Q4
$228K Sell
6,557
-16,366
-71% -$569K ﹤0.01% 1568
2024
Q3
$917K Buy
22,923
+13,408
+141% +$536K ﹤0.01% 1111
2024
Q2
$452K Buy
9,515
+1,660
+21% +$78.9K ﹤0.01% 1235
2024
Q1
$339K Buy
7,855
+1,214
+18% +$52.4K ﹤0.01% 1147
2023
Q4
$335K Buy
6,641
+84
+1% +$4.24K ﹤0.01% 1228
2023
Q3
$296K Buy
6,557
+1,420
+28% +$64.1K ﹤0.01% 1271
2023
Q2
$209K Sell
5,137
-1,051
-17% -$42.8K ﹤0.01% 1331
2023
Q1
$220K Buy
6,188
+2,465
+66% +$87.6K ﹤0.01% 1283
2022
Q4
$139K Sell
3,723
-322
-8% -$12K ﹤0.01% 1398
2022
Q3
$178K Sell
4,045
-1,580
-28% -$69.5K ﹤0.01% 1294
2022
Q2
$207K Buy
5,625
+568
+11% +$20.9K ﹤0.01% 1275
2022
Q1
$186K Sell
5,057
-757
-13% -$27.8K ﹤0.01% 1269
2021
Q4
$176K Buy
5,814
+4,554
+361% +$138K ﹤0.01% 1306
2021
Q3
$42K Sell
1,260
-631
-33% -$21K ﹤0.01% 1767
2021
Q2
$74K Buy
1,891
+1,854
+5,011% +$72.6K ﹤0.01% 1436
2021
Q1
$1K Sell
37
-2,009
-98% -$54.3K ﹤0.01% 1825
2020
Q4
$115K Buy
2,046
+872
+74% +$49K ﹤0.01% 1163
2020
Q3
$55K Sell
1,174
-441
-27% -$20.7K ﹤0.01% 1158
2020
Q2
$95K Sell
1,615
-1,024
-39% -$60.2K ﹤0.01% 1027
2020
Q1
$124K Sell
2,639
-9,931
-79% -$467K ﹤0.01% 967
2019
Q4
$759K Buy
+12,570
New +$759K ﹤0.01% 777
2016
Q4
Sell
-50,000
Closed -$1.83M 1017
2016
Q3
$1.83M Buy
+50,000
New +$1.83M ﹤0.01% 628